Trump administration proposes restrictions on US investment in Chinese biotech sector
The Treasury Department issued proposed rules that would severely restrict future US investment in Chinese biotechnology companies, potentially complicating financial ties as American drugmakers increasingly turn to China for clinical trials and manufacturing.
